Siemens Healthineers obtains first FDA EUA for semi-quantitative antibody test
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
JULABO USA announces the introduction of 'LucaVision' - a revolutionary new approach to customer service based on Augmented Reality from Atheer
The vDelivery service platform now offering free, expert support to get JULABO temperature control units up and running quickly, with more ways to connect virtually
Ideal for cell and gene therapy and COVID-19 research, BioStore IIIv offers inventory control and reporting capabilities
The modular solution aims to deliver test results in a four-step process requiring minimal hands-on time, laboratory space and staffing resources
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
Discover the new methods and innovations driving cannabis research forward - plus, a firsthand account of independent cannabis testing in 2020
New seed varieties introduced with high levels of CBG and a THC-level of below 0.2%
The new devices are designed to be ideal for applications sensitive to magnetic fields
This novel system could offer financial protection from fluctuations in market prices or changes in demand, and mitigate risks associated with an unreliable climate
Smart home technologies are an emerging market, with some households installing voice controlled appliances and smart security
Post-menopausal women with lower levels of the female sex hormone estrogen appear to be at higher risk of developing serious complications of COVID-19
Rice is the most widely consumed staple food source for a large part of the world’s population
Flow cytometry innovator embraces full solutions approach with focus on entire emission spectra
California Laboratories can now instantly transmit covid-19 data to the CalREDIE system
Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer
Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
Join us on Tuesday, August 18, for the essentials on analysis of residual solvents in cannabinoid products, top tips for effective terpenes analysis, and more - all on one instrument